These pathway-level changes were accompanied by reduced expression of transcripts frequently associated with tumor-promoting programs, such as SERPINA1, MDM2, PDGFA, TGFBR1/2, and SPINK1 (Figure 3C). The gene discussed is MDM2; the disease is neoplasm.